Zanidatamab vs trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis
- DOI
- 10.1093/oncolo/oyag270
- Published
- 2026-07-08
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyag270,
title = {Zanidatamab vs trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis},
author = {Federico Nichetti and Floriana Nappo and Francesca Bof and Martina Bosa and Elena Mattiuzzo and Giulia Maddalena and Maria Caterina De Grandis and Sabina Murgioni and Francesca Bergamo and Sara Lonardi},
year = {2026},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyag270},
url = {https://doi.org/10.1093/oncolo/oyag270}
}RIS
TY - JOUR TI - Zanidatamab vs trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis AU - Federico Nichetti AU - Floriana Nappo AU - Francesca Bof AU - Martina Bosa AU - Elena Mattiuzzo AU - Giulia Maddalena AU - Maria Caterina De Grandis AU - Sabina Murgioni AU - Francesca Bergamo AU - Sara Lonardi PY - 2026 JO - The Oncologist DO - 10.1093/oncolo/oyag270 UR - https://doi.org/10.1093/oncolo/oyag270 ER -
APA
Nichetti, F., Nappo, F., Bof, F., Bosa, M., Mattiuzzo, E., Maddalena, G., Grandis, M. C. D., Murgioni, S., Bergamo, F., & Lonardi, S. (2026). Zanidatamab vs trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysis. The Oncologist. https://doi.org/10.1093/oncolo/oyag270
Source records
- crossref · retrieved 2026-09-25T05:40:48.716Z